AstraZeneca: Sister of blood clot victim urges UK to get jabbed
When you subscribe we will use the information you provide to send you these newsletters. Sometimes they’ll include recommendations for other related newsletters or services we offer. Our Privacy Notice explains more about how we use your data, and your rights. You can unsubscribe at any time.
Madrid and Rome last night decided to limit the Oxford-AstraZeneca vaccine to people aged above 60. Their decision ignores an earlier recommendation by EU regulators the EMA that the immunisation was safe to use in all adults. They join a host of EU nations, including Belgium, France and Germany, already restricting the rollout of the Oxford shot because of concerns it causes blood clots.
Spain’s decision to use the AstraZeneca vaccine only for people over 60 is a sharp U-turn on its previous policy that banned the jab for over-55s.
The new rules are expected to hinder prime minister Pedro Sanchez’s ambitions to have 70 percent of the population vaccinated by the end of August.
Isabel Diaz Ayuso, head of the Madrid regional government, slammed the decision.
She said: “You can’t constantly change the criteria.
“You can’t switch halfway through the game when many people are already vaccinated, and when there was at last beginning to be some clarity about which vaccines were for which groups of people.”
So far, 6.4 million Spaniards have received at least one dose of a coronavirus vaccine.
Of those, around 2 million of those were given the Oxford jab, which has seen its use ramped up in recent weeks.
Italian health chiefs last night issued similar guidance, saying the AstraZeneca shot should be given “preferential use” in those aged 60 and above.
The countries changed their advice after an EMA investigation into the Anglo-Swedish firm’s shot found blood clots to be a “very rare” side effect.
The EU’s drugs watchdog noted: “So far, most of the cases reported have occurred in women under 60 years of age within two weeks of vaccination.”
It had hoped that EU nations would adopt a unified position for rolling out the AstraZeneca vaccine.
But capitals have largely opted for their own approach.
MUST READ: Macron’s EU army dream sparks suspicion in Merkel’s camp
Belgium separately restricted use of the Oxford jab to those aged 56 or older for a minimum of four weeks.
France limits it for over-55s and Germany for over-60s, opting to favour the Pfizer and Johnson & Johnson vaccines to boost their vaccination drives.
Britain has also chosen to alter its use of the Oxford vaccine, after a review found a possible link between the vaccine and an increase in the risk of rare blood clots.
Healthy people aged 18 to 29 will now be offered the Pfizer or Moderna vaccines instead.
Brexit news: Spain erupts at EU for punishing UK [INSIGHT]
Under-30s in Britain will NOT get the AstraZeneca jab – MHRA confirms [REVEALED]
Von der Leyen on brink as German court risks recovery fund [ANALYSIS]
This Morning: Nick Ferrari discusses AstraZeneca vaccine
But medical experts have insisted the Oxford-AstraZeneca dose is still safe and played down any fears.
Deputy Chief Medical Officer Professor Jonathan Van-Tam said the change in guidance was not unusual and should not delay the rollout.
He said: “It is a course correction but nevertheless it is full speed ahead with the UK vaccine programme so that we can get life back to normal.”
Boris Johnson thanked the review panel for their work and for explaining “the potential for extremely rare side-effects”.
The Prime Minister said: “As the regulators have said, this vaccine is safe, effective and has already saved thousands of lives – and the vast majority of people should continue to take it when offered.
“We will follow today’s updated advice, which should allow people of all ages to continue to have full confidence in vaccines, helping us save lives and cautiously return towards normality.”
Source: Read Full Article